Skip to main content

Call for cases

The Scientific Committee invites case submissions for presentation at the 18th Congress of the European Society of Minimally Invasive Neurological Therapy. The sharing of science – especially the latest neurointerventional cases – is ever more important, and the ESMINT Congress is the place to do it.

Case submission is now closed. The extended deadline for submission was Wednesday, 29 April 2026, 23:59 CEST.

Congress Recordings

Topics for Case Submissions

  • Aneurysms
  • Brain AVM/AVF and spinal vascular malformations
  • Acute ischemic stroke
  • Innovation & AI
  • Clinical management and regulatory aspects
  • Complications (M&M)
  • INR working environment and equality
  • Venous interventions
  • MMAE
  • INR and neuro-oncology
  • Carotid stenting
  • Paediatric INR
  • ETMINT

ESMINT’s Got Talent

Proposals submitted by presenting authors who are aged 35 or younger (born on or after 9 April 1990) may be considered for the ESMINT’s Got Talent prize. The winner will be invited to give an oral presentation followed by discussion.

If you wish to be considered for this prize, please click the appropriate checkbox during the online submission process.

You will need to upload a copy of your passport with a readily readable date of birth as proof of eligibility. Your complete submission – including passport copy – must arrive by the regular case submission deadline or it will not be considered.

If you have difficulties uploading your passport copy, please contact esmint-congress@aimgroup.eu.

Call for cases: Questions?

If you have questions regarding delegate case proposals or need assistance, please contact the support team at esmint-congress@aimgroup.eu.

Please always specify that you are referring to the ESMINT Congress and use your submission reference number.

Contact support

Guidelines for delegate case presentation proposals

To standardise the layout, we kindly ask you to read the guidelines carefully.

1. Abstracts / Case Reports may be submitted only via the online platform. Reports submitted via fax or email will not be accepted.

2. The report must be submitted in English. Please use UK English spelling.

3. Please make sure that the author’s name and email address are complete and correct.

4. The case body text may not be longer than 300 words.

5. Submitters are requested to submit a case overview body text in the following structure:

I. Background / Introduction (Context and why this case matters)
II. Objective / Purpose (Reason for presenting the case)
III. Methods / Case Description (Detailed case presentation)
IV. Results / Findings (Clinical outcome and key observations)
V. Discussion / Conclusions / Learning Points (Interpretation, implications, and key takeaways)

6. Inclusion of images: max 3. Image Size: 1000 px. Uploading images will affect word count

7. Inclusion of tables: max 3. Max size: 10 x 10 rows

8. There is no limit to the number of abstracts / case reports a researcher may submit. However, researchers should not submit the same case more than once. Submissions that appear to be replicate versions of a single study may be rejected.

9. Please limit the number of authors to those who have substantially contributed to the research. If authors’ names appear on more than one report, their names must appear and be spelled identically on each report in order to facilitate proper indexing. Wherever possible, do not list authors with initials only.

10. Do not use abbreviations in the title. Limit yourself to commonly used abbreviations and explain all abbreviations at first mention.

11. Authors must indicate their presentation type preference: either Poster Presentation Only / Oral Presentation / Both.

After submission:
1. A confirmation email with a reference number will be sent automatically. Submitted abstracts / case reports may be edited until submitting.

2. The Scientific Committee reserves the right to decide the final allocation and presentation type.

3. Presenting authors of accepted abstracts / case reports must register and attend the congress.